CAC
UPH

Cowen and Company’s UpHealth, Inc. UPH Stock Holding History

Cowen and Company’s Portfolio UPH Stock Details UPH Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2020
Q3 		– Sell
-8,080
Closed -$819K – 552
2020
Q2 		$819K Buy
+8,080
New +$809K 0.14% 107

Other funds holding UPH

GCL
Glazer Capital LLC New York $4.71B AUM 81.93% 1-Year Est. Return
FTCM
Fir Tree Capital Management New York $21.8M AUM 1.62% 1-Year Est. Return
WAM
Weiss Asset Management Boston, Massachusetts $5.91B AUM 42.42% 1-Year Est. Return
Hudson Bay Capital Management
Hudson Bay Capital Management Stamford, Connecticut $29B AUM 30.2% 1-Year Est. Return
WRBC
W.R. Berkley Corp Greenwich, Connecticut $1.86B AUM 14.44% 1-Year Est. Return
PC
Periscope Capital Toronto, Ontario, Canada $902M AUM 6.27% 1-Year Est. Return
LA
Linden Advisors New York $17.9B AUM 1.72% 1-Year Est. Return
DKCM
Davidson Kempner Capital Management New York $7.33B AUM 56.47% 1-Year Est. Return
OP
Omni Partners London, United Kingdom $2.03B AUM 126.33% 1-Year Est. Return
AIMCA
Alberta Investment Management Corp (AIMCo) Edmonton, Alberta, Canada $17.9B AUM 27.57% 1-Year Est. Return

Cowen and Company's UPH Position: Q3 2020 in Review

Cowen and Company sold out of UpHealth, Inc. (UPH) in Q3 2020, closing a stake of 8,080 shares — an estimated $819K sold.

Cowen and Company first reported a position in UPH in Q2 2020 and held it in 1 quarter. The position peaked at $819K in Q2 2020. 47 funds tracked by Wall St. Rank hold UPH as of Q3 2020.

  • Cowen and Company reported no remaining UpHealth, Inc. position as of Q3 2020 after selling out during the quarter.
  • Cowen and Company sold 8,080 UpHealth, Inc. shares in Q3 2020, an estimated $819K.
  • Cowen and Company first reported a position in UpHealth, Inc. in Q2 2020 and held it in 1 quarter.
  • Cowen and Company's UpHealth, Inc. position peaked at $819K in Q2 2020.
  • 47 funds tracked by Wall St. Rank held UpHealth, Inc. as of Q3 2020.

Based on Cowen and Company's 13F filing for Q3 2020, filed 3 Nov 2020.